Actavis (ACT) Price Target Raised to $280 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Filing Shows Allergan (AGN), Actavis (ACT) Talks Continue
November 6, 2014 9:23 AM ESTAn SEC filing by Allergan (NYSE: AGN) shows takeover talks with a third party believed to be Actavis Plc (NYSE: ACT) have continued. The text from the filing is below.
"Notwithstanding the foregoing, we have been approached by... More
Valeant Pharma (VRX) on Watch on Actavis/Allergan Headlines
November 6, 2014 9:21 AM ESTValeant Pharma (NYSE: VRX) on watch as Actavis Plc (NYSE: ACT) is said to be in advanced takeover talks with Allergan (NYSE: AGN), according to Bloomberg. Valeant is pursing its own hostile bid for AGN.
... MoreActavis Plc (ACT) said to be in active takeover talks with Allergan (AGN) - Bloomberg
November 6, 2014 9:19 AM ESTActavis Plc (NYSE: ACT) said to be in active takeover talks with Allergan (NYSE: AGN) according to Bloomberg.
... MoreActavis Plc (ACT) Tops Q3 EPS by 9c
November 5, 2014 6:31 AM ESTActavis Plc (NYSE: ACT) reported Q3 EPS of $3.19, $0.09 better than the analyst estimate of $3.10. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.63 billion.
Raises H214 adjusted EPS outlook to $6.60 - $6.70.
For earnings history and earnings-related data on Actavis Plc (ACT) click here.
... More